7 pharma multimillionaires in Africa you should know
Meet seven African entrepreneurs who founded pharma companies worth at least $50 million.
Skip to content
Meet seven African entrepreneurs who founded pharma companies worth at least $50 million.
Rebrab, former CEO of Cevital Group, was placed on May 18 under judicial control by the public prosecutor at the Sidi M’Hamed court.
Balogun, the doyen of investment banking in Nigeria, passed away in London last Friday at 89.
The Rajabali brothers, considered two of Tanzania’s richest individuals, own a combined 2.6-percent stake in CRDB Bank.
Rutakangwa’s entrepreneurial journey and the success of Rwazi highlight the transformative power of technology.
Gap’s lawsuit against West and his Yeezy brand focuses on unapproved alterations made to a rental property in Los Angeles.
Raval founded Devki Group in Nairobi in 1986 as a small steel-processing and trade enterprise.
Swartzberg owns a 3.92-percent stake in the Sandton-based financial services group.
Al-Amoudi holds the 500th spot on the Bloomberg Billionaires Index, with a net worth of $5.05 billion.
Rupert has seen his net worth slide by $800 million amid Richemont’s share slump.
Mbire, the wealthiest investor on the Uganda Stock Exchange. loses $3.6 million as MTN Uganda’s stock price takes a hit.
Adenuga controls a majority stake of 74.4 percent in Conoil.
The group’s impressive financial performance underscores its position as a leading financial institution in the region.
The announcement was made during the launch of the firm’s first-ever public charging station in Nairobi.
The Ndegwa family has strengthens its position in NCBA Group.
Rabiu joins Bloomberg’s billionaires’ list, showcasing Africa’s rising business leaders.